Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-16

Clinical Trial Update: AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring

View source ↗

Summary

A pilot clinical trial evaluating AK+ Guard for outpatient diagnostic accuracy and remote monitoring in hyperkalemia and chronic kidney disease, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AK+ Guard

Snippet

Sponsor: AccurKardia, Inc. | Conditions: Hyperkalemia, Chronic Kidney Disease (Stage 3-4) | Status: RECRUITING